United Therapeutics Corporation Proceeds from Sale of Available-for-sale Securities
United Therapeutics Corporation (UTHR) reported Proceeds from Sale of Available-for-sale Securities of $36.20 million for the 12-month period ending 2010-12-31, per its 10-K filed 2013-02-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2013-02-26
- United Therapeutics Corporation proceeds from sale of available-for-sale securities for fiscal 2010 was $36.20M.
- United Therapeutics Corporation proceeds from sale of available-for-sale securities for fiscal 2008 was $31.85M.
| Period end | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|
| 2010-12-31 | $36.20M 10-K · filed 2013-02-26 |
| 2008-12-31 | $31.85M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |